Variation in effectiveness of the NHS Diabetes Prevention Programme in people diagnosed with non‐diabetic hyperglycaemia by age, sex, BMI, and deprivation: A matched cohort analysis of 69,801 people
Rathi Ravindrarajah, Matt Sutton, Peter Bower, Evangelos Kontopantelis

TL;DR
This study examines how effective the NHS Diabetes Prevention Programme is in preventing diabetes across different age, sex, BMI, and deprivation groups.
Contribution
The study provides evidence that the DPP's effectiveness is consistent across various demographic and health-related factors.
Findings
The DPP was effective in reducing conversion rates from non-diabetic hyperglycaemia to diabetes.
No statistically significant differences in effectiveness were found by age, sex, BMI, or deprivation.
The hazard ratios for conversion to diabetes were not significantly different across the studied subgroups.
Abstract
The NHS Diabetes Prevention Programme (DPP) is a behaviour‐change programme aimed at adults diagnosed with non‐diabetic hyperglycaemia (NDH), who are at higher risk of developing type 2 diabetes mellitus (Diabetes). This paper explores the heterogeneity in the effectiveness of the DPP by age, sex, BMI, and practice location deprivation (IMD). Matched cohort analysis with random‐effects parametric survival models, evaluating the association between referral to the DPP and conversion to diabetes, with interactions fitted for age, sex, BMI, and IMD. 18,470 patients referred to the programme were matched to 51,331 controls. None of the interactions of patient characteristics with referrals were statistically significant. For women, the difference in the HR of conversion to diabetes, compared to men, was HR = 0.94 (95% CI: 0.81, 1.08, p = 0.38); For those aged [18–34], HR = 0.79 (95% CI:…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsDiabetes Management and Education · Chronic Disease Management Strategies · Diabetes, Cardiovascular Risks, and Lipoproteins
